AcelRx Pharma (ACRX) Completes Enrollment in Remaining ARX-04 Phase 3s
Tweet Send to a Friend
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) announced that it has completed patient enrollment in the two remaining Phase 3 studies of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
